KVP International Expands Diagnostics Capabilities with SafePath Acquisition
In a significant move for the diagnostics industry, KVP International, known as The Better Pet Care Company™, has recently announced its acquisition of SafePath-IVD. Based in Carlsbad, California, SafePath-IVD is a premier diagnostics manufacturer with a strong reputation in the field. With this acquisition, KVP strengthens its position as a leading player in the burgeoning veterinary diagnostics market while also opening doors to opportunities in human health diagnostics.
The strategic acquisition comes as KVP seeks to enhance its product offerings in point-of-care and rapid diagnostic solutions. By integrating SafePath-IVD into its operations, KVP aims to leverage the expertise and experience of SafePath's established scientific team.
David Lambillotte, the VP of Business Development at SafePath-IVD, expressed enthusiasm about the new partnership, highlighting the potential for improving diagnostic tools for veterinarians and pet owners alike. "We are thrilled to partner with KVP and look forward to the continued introduction of novel diagnostics that deliver superior point-of-care results while providing great value to both the pet owner and veterinarian," he remarked.
KVP's CEO, Ken Bowman, welcomed the acquisition as a major enhancement to the company's efforts in advancing diagnostic innovations worldwide. SafePath-IVD's strengths in research, development, and manufacturing will support KVP's growing diagnostic lines significantly. The collaboration is expected to accelerate the development of new tests and technologies that complement KVP's existing product portfolio.
SafePath-IVD will maintain its autonomy under its current leadership team, ensuring a continuity of its scientific capabilities and multi-market focus. With the infusion of KVP's investment, SafePath plans to expand its infrastructure, boosting development efforts and increasing manufacturing capacity to meet the rising global demand for diagnostics.
The partnership is poised to yield substantial benefits for both companies. As they combine resources and expertise, they aim to set new benchmarks for accessible, accurate, and scalable diagnostics in veterinary care and human health. The collaboration is anticipated to raise the standards of existing diagnostic practices, thereby ensuring better healthcare outcomes for both pets and their owners.
This acquisition reflects KVP’s commitment to enhancing veterinary health services through innovative solutions while securing a competitive edge in the human healthcare sector. By pooling their resources, KVP and SafePath-IVD plan to create a more integrated, responsive approach to medical diagnostics, ultimately contributing to advancements in both veterinary and human healthcare industries.
Founded in 1964, KVP has a long-standing legacy as a trusted provider of veterinary consumables, diagnostics, and patient care products, serving professionals across more than 30 countries. With suppliers, hospitals, and veterinary professionals relying on KVP’s commitment to quality and innovation, the company looks forward to evolving its operations further to cater to an increasingly demanding market.
For more information on KVP International and its latest advancements, including details about its newly acquired division, SafePath-IVD, interested parties can visit their website at www.kvpvet.com.